These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11038688)

  • 21. Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin.
    Wu C; Ying H; Grinnell C; Bryant S; Miller R; Clabbers A; Bose S; McCarthy D; Zhu RR; Santora L; Davis-Taber R; Kunes Y; Fung E; Schwartz A; Sakorafas P; Gu J; Tarcsa E; Murtaza A; Ghayur T
    Nat Biotechnol; 2007 Nov; 25(11):1290-7. PubMed ID: 17934452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Manufacture of recombinant polyclonal antibodies.
    Rasmussen SK; Rasmussen LK; Weilguny D; Tolstrup AB
    Biotechnol Lett; 2007 Jun; 29(6):845-52. PubMed ID: 17310321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Industrial processes with animal cells.
    Kretzmer G
    Appl Microbiol Biotechnol; 2002 Jul; 59(2-3):135-42. PubMed ID: 12111138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of humanized anti-DNA hydrolyzing catalytic antibodies by complementarity determining region grafting.
    Kim DS; Lee SH; Kim JS; Lee SC; Kwon MH; Kim YS
    Biochem Biophys Res Commun; 2009 Feb; 379(2):314-8. PubMed ID: 19103171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant antibody technology: its advent and advances.
    Hozumi N; Sandhu JS
    Cancer Invest; 1993; 11(6):714-23. PubMed ID: 8221205
    [No Abstract]   [Full Text] [Related]  

  • 26. Bispecific antibodies for cancer therapy.
    Chames P; Baty D
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):276-83. PubMed ID: 19333873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and manufacture of monoclonal antibodies for radioimmunotherapy.
    Hale G; Berrie E; Bird P
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):258-66. PubMed ID: 15640789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody cocktails: next-generation biopharmaceuticals with improved potency.
    Logtenberg T
    Trends Biotechnol; 2007 Sep; 25(9):390-4. PubMed ID: 17681390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody engineering: facing new challenges in cancer therapy.
    Sanz L; Cuesta AM; Compte M; Alvarez-Vallina L
    Acta Pharmacol Sin; 2005 Jun; 26(6):641-8. PubMed ID: 15916728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The rapid discovery of engineered antibodies.
    Wang M; He M
    IDrugs; 2007 Aug; 10(8):562-5. PubMed ID: 17665332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engineering novel antibody molecules.
    Sensel MG; Coloma MJ; Harvill ET; Shin SU; Smith RI; Morrison SL
    Chem Immunol; 1997; 65():129-58. PubMed ID: 9018876
    [No Abstract]   [Full Text] [Related]  

  • 32. Engineered antibodies.
    Hudson PJ; Souriau C
    Nat Med; 2003 Jan; 9(1):129-34. PubMed ID: 12514726
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapeutic monoclonal antibodies: a little history, a lot of engineering, and... some clinical successes].
    Siberil S; Dutertre CA; Boix C; Teillaud JL
    Transfus Clin Biol; 2005 Jun; 12(2):114-22. PubMed ID: 15907389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plant biopharming of monoclonal antibodies.
    Ko K; Koprowski H
    Virus Res; 2005 Jul; 111(1):93-100. PubMed ID: 15896408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humanized antibodies as potential drugs for therapeutic use.
    Merluzzi S; Figini M; Colombatti A; Canevari S; Pucillo C
    Adv Clin Path; 2000 Apr; 4(2):77-85. PubMed ID: 11080787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production of chimeric monoclonal antibodies by genetically manipulated chickens.
    Kamihira M; Kawabe Y; Shindo T; Ono K; Esaka K; Yamashita T; Nishijima K; Iijima S
    J Biotechnol; 2009 Apr; 141(1-2):18-25. PubMed ID: 19428726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of humanized IgGs in glycoengineered Pichia pastoris.
    Li H; Sethuraman N; Stadheim TA; Zha D; Prinz B; Ballew N; Bobrowicz P; Choi BK; Cook WJ; Cukan M; Houston-Cummings NR; Davidson R; Gong B; Hamilton SR; Hoopes JP; Jiang Y; Kim N; Mansfield R; Nett JH; Rios S; Strawbridge R; Wildt S; Gerngross TU
    Nat Biotechnol; 2006 Feb; 24(2):210-5. PubMed ID: 16429149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probing lipase/esterase libraries for lipid A hydrolases--discovery of biocatalysts for the detoxification of bacterially-expressed recombinant protein.
    Ahn JM; Wentworth P; Janda KD
    Chem Commun (Camb); 2004 Feb; (4):364-5. PubMed ID: 14765210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineered antibodies take center stage.
    Huston JS; George AJ
    Hum Antibodies; 2001; 10(3-4):127-42. PubMed ID: 11847424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Designer genes: recombinant antibody fragments for biological imaging.
    Wu AM; Yazaki PJ
    Q J Nucl Med; 2000 Sep; 44(3):268-83. PubMed ID: 11105590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.